Literature DB >> 30126898

RocA Has Serotype-Specific Gene Regulatory and Pathogenesis Activities in Serotype M28 Group A Streptococcus.

Paul E Bernard1,2, Priyanka Kachroo1, Luchang Zhu1, Stephen B Beres1, Jesus M Eraso1, Zaid Kajani1, S Wesley Long1,3, James M Musser1,3, Randall J Olsen4,2,3.   

Abstract

Serotype M28 group A streptococcus (GAS) is a common cause of infections such as pharyngitis ("strep throat") and necrotizing fasciitis ("flesh-eating" disease). Relatively little is known about the molecular mechanisms underpinning M28 GAS pathogenesis. Whole-genome sequencing studies of M28 GAS strains recovered from patients with invasive infections found an unexpectedly high number of missense (amino acid-changing) and nonsense (protein-truncating) polymorphisms in rocA (regulator of Cov), leading us to hypothesize that altered RocA activity contributes to M28 GAS molecular pathogenesis. To test this hypothesis, an isogenic rocA deletion mutant strain was created. Transcriptome sequencing (RNA-seq) analysis revealed that RocA inactivation significantly alters the level of transcripts for 427 and 323 genes at mid-exponential and early stationary growth phases, respectively, including genes for 41 transcription regulators and 21 virulence factors. In contrast, RocA transcriptomes from other GAS M protein serotypes are much smaller and include fewer transcription regulators. The rocA mutant strain had significantly increased secreted activity of multiple virulence factors and grew to significantly higher colony counts under acid stress in vitro RocA inactivation also significantly increased GAS virulence in a mouse model of necrotizing myositis. Our results demonstrate that RocA is an important regulator of transcription regulators and virulence factors in M28 GAS and raise the possibility that naturally occurring polymorphisms in rocA in some fashion contribute to human invasive infections caused by M28 GAS strains.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  RocA; group A streptococcus; molecular pathogenesis; virulence

Mesh:

Substances:

Year:  2018        PMID: 30126898      PMCID: PMC6204712          DOI: 10.1128/IAI.00467-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  105 in total

1.  Heterogeneity of the streptokinase gene in group A streptococci.

Authors:  T T Huang; H Malke; J J Ferretti
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

2.  Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity.

Authors:  Nicole M Green; Shizhen Zhang; Stephen F Porcella; Michal J Nagiec; Kent D Barbian; Stephen B Beres; Rance B LeFebvre; James M Musser
Journal:  J Infect Dis       Date:  2005-07-29       Impact factor: 5.226

3.  Comparative functional analysis of the lac operons in Streptococcus pyogenes.

Authors:  Jennifer A Loughman; Michael G Caparon
Journal:  Mol Microbiol       Date:  2007-03-19       Impact factor: 3.501

4.  Null Mutations of Group A Streptococcus Orphan Kinase RocA: Selection in Mouse Infection and Comparison with CovS Mutations in Alteration of In Vitro and In Vivo Protease SpeB Expression and Virulence.

Authors:  Wenchao Feng; Dylan Minor; Mengyao Liu; Jinquan Li; Suzanne L Ishaq; Carl Yeoman; Benfang Lei
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

5.  Deletion of from Streptococcus pyogenes. Results in Hypervirulence in a Mouse Model of Sepsis and is LuxS Independent.

Authors:  Izabela Sitkiewicz; James M Musser
Journal:  Pol J Microbiol       Date:  2017-03-30

6.  Identification of rocA, a positive regulator of covR expression in the group A streptococcus.

Authors:  Indranil Biswas; June R Scott
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

7.  A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection.

Authors:  Samuel A Shelburne; Randall J Olsen; Bryce Suber; Pranoti Sahasrabhojane; Paul Sumby; Richard G Brennan; James M Musser
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

8.  A molecular trigger for intercontinental epidemics of group A Streptococcus.

Authors:  Luchang Zhu; Randall J Olsen; Waleed Nasser; Stephen B Beres; Jaana Vuopio; Karl G Kristinsson; Magnus Gottfredsson; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

Review 9.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.

Authors:  B Vlaminckx; W van Pelt; L Schouls; A van Silfhout; C Elzenaar; E Mascini; J Verhoef; J Schellekens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-26       Impact factor: 3.267

View more
  7 in total

1.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

2.  To be capsulated or not be capsulated: that is the GAS question.

Authors:  Roberta Creti; Giovanni Gherardi; Monica Imperi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-13       Impact factor: 3.267

Review 3.  Porphyromonas gingivalis outside the oral cavity.

Authors:  Steeve Bregaint; Emile Boyer; Shao Bing Fong; Vincent Meuric; Martine Bonnaure-Mallet; Anne Jolivet-Gougeon
Journal:  Odontology       Date:  2021-08-19       Impact factor: 2.634

4.  Single Amino Acid Replacements in RocA Disrupt Protein-Protein Interactions To Alter the Molecular Pathogenesis of Group A Streptococcus.

Authors:  Paul E Bernard; Amey Duarte; Mikhail Bogdanov; James M Musser; Randall J Olsen
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

5.  Gene fitness landscape of group A streptococcus during necrotizing myositis.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Jesus M Eraso; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Amelia R L Charbonneau; Andrew S Waller; James M Musser
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

6.  RocA Binds CsrS To Modulate CsrRS-Mediated Gene Regulation in Group A Streptococcus.

Authors:  Nicola N Lynskey; Jorge J Velarde; Meredith B Finn; Simon L Dove; Michael R Wessels
Journal:  mBio       Date:  2019-07-16       Impact factor: 7.867

7.  The group A Streptococcus accessory protein RocA: regulatory activity, interacting partners and influence on disease potential.

Authors:  Ira Jain; Jessica L Danger; Cameron Burgess; Timsy Uppal; Paul Sumby
Journal:  Mol Microbiol       Date:  2019-11-11       Impact factor: 3.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.